
The Biden administration has declared fentanyl laced or associated with xylazine as an “emerging threat” to the United States, the White House announced Wednesday.
It is the first time any administration has designated a drug as an evolving and emerging threat since Congress passed The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment Act in 2018, Rahul Gupta, MD, MPH, FACP, MBA, the director of the White House Office of National Drug Control Policy (ONDCP), said in a press release.
“As a physician, I am deeply troubled about the devastating impact